Immuno Oncology (I-O) Market Size, Trends, Industry Analysis By Treatment Approaches (Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines); By Novel Targets (IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i); By Tumor Types; By Region: Market Size & Forecast, 2020 – 2025

Report Content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Overview
  • Financials
  • Drug Type benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecasts from 2017 – 2025
• Market revenue estimates for Treatment Approaches up to 2025
• Market revenue estimates for Novel Targets up to 2025
• Market revenue estimates for Tumor Types up to 2025
• Regional market size and forecast for Treatment Approaches up to 2025
• Regional market size and forecast for Novel Targets up to 2025
• Regional market size and forecast for Tumor Types segments up to 2025
• Company financials